Virtus Fund Advisers’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $109K | Buy |
|
|||||
|
2024
Q3 | $88.5K | Hold |
|
|||||
|
2024
Q2 | $106K | Buy |
|
|||||
|
2024
Q1 | $103K | Buy |
|
|||||
|
2023
Q4 | $90.5K | Buy |
|
|||||
|
2023
Q3 | $45.2K | Buy |
|
|||||
|
2017
Q4 | $1.38M | Buy |
|
|||||
|
2017
Q3 | $325K | Sell |
|
|||||
|
2017
Q2 | $263K | Sell |
|
|||||
|
2017
Q1 | $251K | Sell |
|
|||||
|
2016
Q4 | $345K | Sell |
|
|||||
|
2016
Q3 | $606K | Hold |
|
|||||
|
2016
Q2 | $542K | Hold |
|
|||||
|
2016
Q1 | $473K | Sell |
|
|||||
|
2015
Q4 | $821K | Sell |
|
|||||
|
2015
Q3 | $583K | Sell |
|
|||||
|
2015
Q2 | $2.8M | Sell |
|
|||||
|
2015
Q1 | $2.36M | Sell |
|
|||||
|
2014
Q4 | $1.45M | Buy |
|
|||||
|
2014
Q3 | $1.01M | Sell |
|
|||||
|
2014
Q2 | $1.05M | Buy |
|